Patents

Fall Flash Sale! Save Up to 35% Off. Shop Now

Free shipping on all orders

Your cart is empty

Protection Behind Our Ingredient

Acquiring intellectual property protection for our key ingredient ensures you’re getting the only safe, high-quality NIAGEN® (nicotinamide riboside) from its patent holder in every batch. NIAGEN® is protected under the following patents in these territories:

United States

8,114,626
7,776,326

9,295,688
10,000,519
10,688,118
10,857,172

11,033,568
11,071,747
11,242,364
11,274,117
11,345,720

International Filing and Issued Patents

China

CN1964627
CN105636973

Hong Kong

HK1218918

Europe

EP1755391
EP3027635
EP3063163

Australia

2006238858
2014342185
2014298629

Canada

2609633
2928656

Japan

JP6208352
JP6509844
JP7061077
JP7136795

South Africa

ZA201600908
ZA201603314
ZA201807586

Mexico

349969
385305
394291

New Zealand

716277
719328

Brazil

112016001774

Indonesia

201800430

India

364502

Korea

102303966
102450537

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

**Based on registered ongoing or completed clinical trials under "nicotinamide riboside" on clinicaltrials.gov.

***Based on the top selling dietary supplement brands by revenue per the largest U.S. ecommerce marketplace [identified through a search dated March 1, 2023 – Feb. 29. 2024 using “NAD precursors”]

^†In combination with a healthy lifestyle.

^‡In reference to physiological (not mental) stress.

Your cart